Molecule Catalog Mapping for Bioactivity-Relevant Drug Candidate Search
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing drug discovery processes face inefficiencies in identifying potential drug candidates due to low relevance of structurally similar molecules and prohibitive computational complexity in molecule catalog searches, leading to wasted time and resources.
Innovation Solution
A method involving edit heuristics and mapping algorithms to generate derived molecule specifications, allowing for efficient search operations across large molecule catalogs while preserving target bioactivity, reducing computational complexity regardless of catalog size.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If similarity metrics are used to identify potential drug candidates, then structurally similar molecules are found, but the fraction of candidates with the same target bioactivity is low
Solution Approach 1:
The patent transforms the search approach by changing from structural similarity parameters to bioactivity-based parameters. Instead of comparing molecular structures using Tanimoto coefficients, the system uses machine learning models trained on bioactivity data to predict and compare actual biological effects, thereby identifying molecules with relevant bioactivities rather than just structural similarities
Solution Approach 2:
The patent replaces the traditional chemical structure comparison mechanism with a data-driven machine learning mechanism. Rather than using chemical information systems that compare molecular graphs and fragments, the system employs trained ML models that process molecular representations to predict bioactivities, substituting chemical expertise with learned patterns from large datasets
2Reliability
If comprehensive molecule catalog searches are performed, then all available molecules are evaluated, but the computational time and resources required are prohibitive
Solution Approach 1:
The patent applies partial action by using pre-trained machine learning models that have already learned from extensive training data. Instead of performing exhaustive evaluations of all molecules from scratch, the system uses these pre-trained models to quickly predict bioactivities, achieving comprehensive search coverage with reduced computational effort through the reuse of previously learned knowledge
Solution Approach 2:
The patent performs preliminary action by pre-training machine learning models on large datasets of molecular structures and their corresponding bioactivities before the actual drug discovery search. This pre-training phase captures general patterns and relationships, enabling the models to rapidly evaluate new molecules without requiring exhaustive computational analysis during the actual search process
Data Source
AI summary
In various embodiments, a molecule exploration application determines one or more potential drug candidates during a drug discovery process. The molecule exploration application generates derived molecule specifications based on a query molecule specification and edit heuristics. Subsequently, the molecule exploration application performs, via a mapping algorithm, one or more mapping operations on the derived molecule specifications to generate mapped molecule specifications. The molecule exploration application then performs one or more search operations on a mapped catalog of molecules based on the mapped molecule specifications to determine the one or more potential drug candidates. Advantageously, the molecule exploration application can be used to efficiently determine additional drug development candidates during a drug discovery process.